Heart pump study for advanced heart failure
Part of Heart & circulation clinical trials.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- Have very advanced heart failure (class IV) with poor pumping function
- Be able to give informed consent
- Meet certain additional criteria showing the heart is failing despite best medical treatment
- Not have other serious health conditions or be on other investigational treatments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This study follows people who have already received the Corheart 6 heart pump to see how well it works over time. You may qualify if you have severe heart failure that doesn't improve with standard treatments and you got the pump after October 1, 2021.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This study tests a new type of heart pump (the DuoCor 2) designed to support both the left and right sides of the heart. The pump is implanted during surgery and may help people with very advanced heart failure feel better and live longer.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
Hear when a new Advanced Left Ventricular Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.